Nuformix (LON:NFX) Stock Price Up 4.4% – Should You Buy?

Nuformix plc (LON:NFX)’s share price was up 4.4% during mid-day trading on Friday . The company traded as high as GBX 0.14 and last traded at GBX 0.14. Approximately 20,339,689 shares were traded during mid-day trading, a decline of 32% from the average session volume of 29,953,295 shares. The stock had previously closed at GBX 0.14.

Nuformix Price Performance

The firm has a market capitalization of £3.68 million, a P/E ratio of -4.81 and a beta of 1.52. The business’s 50-day moving average is GBX 0.17 and its 200 day moving average is GBX 0.19.

Nuformix (LON:NFX) last posted its quarterly earnings data on Thursday, May 28th. The company reported GBX (0.02) earnings per share (EPS) for the quarter.

Nuformix Company Profile

Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. It also has an option agreement with Oxilio Ltd. for NXP001 for oncology indications.